Among the NPC patients who received the antitumor therapy, the reoccurrence and lymph node metastasis rates of the patients with higher E-cadherin expression were lower than those with lower E-cadherin expression. This evidence concerns the gene CDH1 and metastatic malignant neoplasm in the lymph nodes.